{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:19:35Z","timestamp":1763036375243},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.cancergencyto.2008.11.003","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T13:30:23Z","timestamp":1234359023000},"page":"105-111","source":"Crossref","is-referenced-by-count":15,"title":["Histopathological criteria and selection algorithms for BRCA1 genetic testing"],"prefix":"10.1016","volume":"189","author":[{"given":"Dorothea","family":"Gadzicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Milde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Steinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Joachim","family":"L\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.11.003_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11154-007-9038-0","article-title":"Genetic susceptibility to breast cancer","volume":"8","author":"Bradbury","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [Erratum in: Nature 2007;447:346]","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","article-title":"Triple negative tumours: a critical review","volume":"52","author":"Reis-Filho","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1524-4741.2007.00516.x","article-title":"Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology","volume":"14","author":"Silva","year":"2008","journal-title":"Breast J"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib6","first-page":"355","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [Erratum in: Ann Intern Med 2005;143:547]","volume":"143","author":"U.S. Preventive Services Task Force","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib7","series-title":"Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer (NICE guidelines CG014)","author":"McIntosh","year":"2004"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1023\/A:1008389021382","article-title":"Recommendations for management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee","volume":"9","author":"Eisinger","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-2003-44815","volume":"125","author":"Schmutzler","year":"2003","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO","volume":"94","author":"Euhus","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2007.04.023","article-title":"Genetic epidemiology of BRCA mutations: family history detects less than 50% of the mutation carriers","volume":"43","author":"Moller","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","article-title":"Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage","volume":"77","author":"Marcus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00313020220147113","article-title":"The pathology of inherited breast cancer","volume":"34","author":"Armes","year":"2002","journal-title":"Pathology"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/modpathol.3800453","article-title":"The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications","volume":"18","author":"Honrado","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib17","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated\u00a0observation of breast tumor subtypes in independent gene\u00a0expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib18","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","article-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","volume":"95","author":"Foulkes","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib19","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","article-title":"Breast Cancer Linkage Consortium. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype","volume":"11","author":"Lakhani","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib20","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1038\/sj.onc.1209876","article-title":"Basal-like breast cancer and the BRCA1 phenotype","volume":"25","author":"Turner","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/bcr13","article-title":"The pathology of familial breast cancer: clinical and genetic counselling implications of breast cancer pathology","volume":"1","author":"Lalloo","year":"1999","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib22","first-page":"1206","article-title":"Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer","volume":"60","author":"Lidereau","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib23","first-page":"1739","article-title":"Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients","volume":"7","author":"Chang","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.pas.0000213273.22844.1a","article-title":"Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing","volume":"30","author":"Farshid","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","article-title":"Optimal selection of individuals for BRCA mutation testing: a comparison of available methods","volume":"24","author":"James","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.1626","article-title":"German Consortium for Familial Breast and Ovarian Cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population","volume":"97","author":"Meindl","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib27","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","article-title":"Limited family structure and BRCA gene mutation status in single cases of breast cancer","volume":"297","author":"Weitzel","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumour biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"J\u00f3hannsson","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W","article-title":"Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes","volume":"83","author":"Loman","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/bcr11","article-title":"The pathology of familial breast cancer: immunohistochemistry and molecular analysis","volume":"1","author":"Osin","year":"1999","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib31","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2200::AID-CNCR14>3.0.CO;2-S","article-title":"Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women","volume":"85","author":"Noguchi","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib32","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib33","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","article-title":"Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type","volume":"10","author":"Foulkes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib34","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr953","article-title":"Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families","volume":"7","author":"Eerola","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1005830230664","article-title":"BRCA2 hereditary breast cancer pathophenotype","volume":"44","author":"Marcus","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005853022804","article-title":"Inherited BRCA2 mutation associated with high grade breast cancer","volume":"47","author":"Agnarsson","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10897-007-9090-7","volume":"16","author":"Berliner","year":"2007","journal-title":"J Genet Couns"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U","article-title":"Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations","volume":"27","author":"Cortesi","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2008.11.003_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jcp.2005.032151","article-title":"Distinction between hereditary and sporadic breast cancers on the basis of clinicopathological data","volume":"59","author":"Van der Groep","year":"2006","journal-title":"J Clin Pathol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016546080800664X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016546080800664X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T22:29:05Z","timestamp":1545431345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016546080800664X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S016546080800664X"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.11.003","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}